A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
EXOSENS operates in the Hardware, Equipment & Parts industry, Technology sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | 530M | 530M | 414M | 317M |
| Net Income | 48M | 48M | 33M | 20M |
| EPS | $0.95 | $0.95 | $0.66 | $0.26 |
| Free Cash Flow | 122M | 122M | 107M | 55M |
| ROIC | 19.0% | 13.3% | 10.7% | 6.8% |
| Gross Margin | - | - | - | - |
| Debt/Equity | 0.00 | 0.56 | 0.61 | 1.68 |
| Dividends/Share | $0.11 | $0.00 | $0.00 | $0.00 |
| Operating Income | 115M | 115M | 83M | 52M |
| Operating Margin | 21.8% | 21.8% | 20.0% | 16.5% |
| ROE | 9.6% | 10.2% | 9.9% | 9.0% |
| Shares Outstanding | 51M | 51M | 50M | 77M |
| Metric | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 317M | 414M | 530M | 530M |
| Gross Margin | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A |
| EBIT | 52M | 83M | 115M | 115M |
| Op. Margin | 16.5% | 20.0% | 21.8% | 21.8% |
| Net Income | 20M | 33M | 48M | 48M |
| Net Margin | 6.3% | 8.0% | 9.1% | 9.1% |
| Non-Recurring | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||
| ROIC | 6.8% | 10.7% | 13.3% | 19.0% |
| ROE | 9.0% | 9.9% | 10.2% | 9.6% |
| ROA | 2.8% | 4.2% | 5.2% | 4.9% |
| Cash Flow | ||||
| Op. Cash Flow | 55M | 107M | 122M | 122M |
| Free Cash Flow | 55M | 107M | 122M | 122M |
| Owner Earnings | 53M | 104M | 115M | 115M |
| CapEx | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | 0 |
| D&A | 0 | 0 | 0 | 0 |
| CapEx/OCF | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||
| Dividends Paid | 0 | 0 | 5.7M | 5.7M |
| Dividend Yield | N/A | N/A | 0.3% | 0.2% |
| Share Buybacks | 0 | 0 | 9.9M | 9.9M |
| Buyback Yield | 0.0% | 0.0% | 0.3% | 0.3% |
| Stock-Based Comp | 1.7M | 3.1M | 6.5M | 6.5M |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||
| Net Debt | 355M | 144M | 205M | -78M |
| Cash & Equiv. | 17M | 127M | 78M | 78M |
| Long-Term Debt | N/A | 268M | 282M | 282M |
| Debt/Equity | 1.68 | 0.61 | 0.56 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | N/A |
| Equity | 222M | 446M | 505M | 505M |
| Total Assets | 713M | 883M | 995M | 995M |
| Total Liabilities | 491M | 437M | 490M | 490M |
| Intangibles | N/A | 221M | 256M | 256M |
| Retained Earnings | N/A | N/A | N/A | N/A |
| Working Capital | 90M | 224M | 189M | 189M |
| Current Assets | 209M | 339M | 317M | 317M |
| Current Liabilities | 120M | 116M | 129M | 129M |
| Per Share Data | ||||
| EPS | 0.26 | 0.66 | 0.95 | 0.95 |
| Owner EPS | 0.69 | 2.06 | 2.26 | 2.26 |
| Book Value | 2.89 | 8.86 | 9.92 | 9.92 |
| Cash Flow/Share | 0.71 | 2.12 | 2.39 | 0.95 |
| Dividends/Share | 0.00 | 0.00 | 0.00 | 0.11 |
| Shares Out. | 76.7M | 50.3M | 50.9M | 50.9M |
| Valuation | ||||
| P/E Ratio | N/A | 30.1 | 59.2 | 66.9 |
| P/FCF | N/A | 9.3 | 23.6 | 26.6 |
| EV/EBIT | N/A | 13.7 | 26.6 | 27.4 |
| Price/Book | N/A | 2.2 | 5.7 | 6.4 |
| Price/Sales | N/A | 2.4 | 5.4 | 6.1 |
| FCF Yield | N/A | 10.7% | 4.2% | 3.8% |
| Market Cap | 0 | 996M | 2.9B | 3.2B |
| Avg. Price | 0.00 | 22.00 | 42.47 | 63.65 |
| Year-End Price | 0.00 | 19.81 | 56.33 | 63.65 |
EXOSENS passes 4 of 9 quality checks, suggesting mixed fundamentals.
EXOSENS trades at 66.9x trailing earnings, compared to its 15-year median P/E of 44.6x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 26.6x vs a median of 16.5x. The company's 5-year average ROIC is 10.3%. Total shareholder yield (dividends + buybacks) is 0.5%. At current prices, the estimated annualized return to fair value is +16.2%.
EXOSENS (EXENS-PA) has a current P/E ratio of 66.9, compared to its historical median P/E of 44.6. The stock is currently considered Expensive based on its historical valuation range.
EXOSENS (EXENS-PA) has a 5-year average return on invested capital (ROIC) of 10.3%. This indicates solid capital allocation.
EXOSENS (EXENS-PA) has a market capitalization of $3.2B. It is classified as a mid-cap stock.
Yes, EXOSENS (EXENS-PA) pays a dividend with a trailing twelve-month yield of 0.18%. The company also returns capital through share buybacks, with a buyback yield of 0.31%.
Based on historical P/E analysis, EXOSENS (EXENS-PA) appears expensive. The current P/E of 66.9 is 50% above its historical median of 44.6. The estimated fair value CAGR (P/E method) is 25.0%.
EXOSENS (EXENS-PA) operates in the Hardware, Equipment & Parts industry, within the Technology sector.
EXOSENS (EXENS-PA) reported annual revenue of $530 million in its most recent fiscal year, based on SEC EDGAR filings.
EXOSENS (EXENS-PA) has a net profit margin of 9.1%. This is a modest margin.
EXOSENS (EXENS-PA) generated $122 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
EXOSENS (EXENS-PA) has a debt-to-equity ratio of 0.56. This indicates moderate leverage.
EXOSENS (EXENS-PA) reported earnings per share (EPS) of $0.95 in its most recent fiscal year.
EXOSENS (EXENS-PA) has a return on equity (ROE) of 10.2%. This indicates moderate shareholder returns.
The Ledger Terminal provides 3 years of financial data for EXOSENS (EXENS-PA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
EXOSENS (EXENS-PA) has a book value per share of $9.92, based on its most recent annual SEC filing.